| 1 |
35119498 | Comparison of characteristics and tumor targeting properties of extracellular vesicles derived from primary NK cells or NK-cell lines stimulated with IL-15 or IL-12/15/18. | 2022 Feb 4 |
2 |
| 2 |
35309907 | Mechanisms of Senescence-Related NKG2D Ligands Release and Immune Escape Induced by Chemotherapy in Neuroblastoma Cells. | 2022 |
1 |
| 3 |
33779082 | Clinical Impact of Natural Killer Group 2D Receptor Expression and That of Its Ligand in Ovarian Carcinomas: A Retrospective Study. | 2021 Apr |
1 |
| 4 |
32996653 | Metabolism of short-chain fatty acid propionate induces surface expression of NKG2D ligands on cancer cells. | 2020 Nov |
1 |
| 5 |
33266137 | An Anti-MICA/B Antibody and IL-15 Rescue Altered NKG2D-Dependent NK Cell Responses in Hepatocellular Carcinoma. | 2020 Nov 30 |
2 |
| 6 |
30845699 | Ex Vivo Expanded Human Vγ9Vδ2 T-Cells Can Suppress Epithelial Ovarian Cancer Cell Growth. | 2019 Mar 6 |
2 |
| 7 |
31661135 | Gene targets of sulforaphane in head and neck squamous cell carcinoma. | 2019 Dec |
1 |
| 8 |
29555675 | NKG2D-MICA Interaction: A Paradigm Shift in Innate Recognition. | 2018 Apr 1 |
1 |
| 9 |
29741244 | Enhanced Th1 and inflammatory mRNA responses upregulate NK cell cytotoxicity and NKG2D ligand expression in human pre-eclamptic placenta and target it for NK cell attack. | 2018 Jul |
2 |
| 10 |
30327650 | HCMV-Encoded NK Modulators: Lessons From in vitro and in vivo Genetic Variation. | 2018 |
1 |
| 11 |
27868339 | FasL and the NKG2D receptor are required for the secretion of the Tag7/PGRP-S-Hsp70 complex by the cytotoxic CD8+ lymphocytes. | 2017 Jan |
1 |
| 12 |
28031333 | T Cells Infiltrating Diseased Liver Express Ligands for the NKG2D Stress Surveillance System. | 2017 Feb 1 |
3 |
| 13 |
28177768 | Ethanol-dependent expression of the NKG2D ligands MICA/B in human cell lines and leukocytes. | 2017 Apr |
3 |
| 14 |
28245380 | [Decitabine Enhances the Sensitivity of Leukemia Stem Cell to Allo-NK Cell-Mediated Killing]. | 2017 Feb |
1 |
| 15 |
28423623 | Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion. | 2017 Mar 21 |
2 |
| 16 |
28433635 | Prognostic significance and functional implication of immune activating receptor NKG2D in gastric cancer. | 2017 Jun 3 |
1 |
| 17 |
28559451 | A disease-linked ULBP6 polymorphism inhibits NKG2D-mediated target cell killing by enhancing the stability of NKG2D ligand binding. | 2017 May 30 |
1 |
| 18 |
28677817 | Inhibition of the HDAC/Suv39/G9a pathway restores the expression of DNA damage-dependent major histocompatibility complex class I-related chain A and B in cancer cells. | 2017 Aug |
1 |
| 19 |
28701757 | Oncolytic measles virus enhances antitumour responses of adoptive CD8+NKG2D+ cells in hepatocellular carcinoma treatment. | 2017 Jul 12 |
2 |
| 20 |
26122035 | Release of Soluble Ligands for the Activating NKG2D Receptor: One More Immune Evasion Strategy Evolved by HIV-1 ? | 2016 |
2 |
| 21 |
26563374 | Differential expression of ligands for NKG2D and DNAM-1 receptors by epithelial ovarian cancer-derived exosomes and its influence on NK cell cytotoxicity. | 2016 Apr |
1 |
| 22 |
26608587 | Overexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinoma. | 2016 Feb |
1 |
| 23 |
26940474 | MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small cell lung cancer. | 2016 May |
2 |
| 24 |
27175912 | Cytotoxic activity of allogeneic natural killer cells on U251 glioma cells in vitro. | 2016 Jul |
1 |
| 25 |
27633040 | Tetramethypyrazine inhibits renal cell carcinoma cells through inhibition of NKG2D signaling pathways. | 2016 Oct |
2 |
| 26 |
24352446 | Hepatitis C virus impairs natural killer cell-mediated augmentation of complement synthesis. | 2014 Mar |
1 |
| 27 |
24718859 | Immunological visibility: posttranscriptional regulation of human NKG2D ligands by the EGF receptor pathway. | 2014 Apr 9 |
1 |
| 28 |
24813230 | Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression. | 2014 Sep |
2 |
| 29 |
24997223 | MICA/B expression in macrophage foam cells infiltrating atherosclerotic plaques. | 2014 Aug |
2 |
| 30 |
22964480 | Regulation of NKG2D-ligand cell surface expression by intracellular calcium after HDAC-inhibitor treatment. | 2013 Mar |
1 |
| 31 |
23282955 | Potential for enhanced therapeutic activity of biological cancer therapies with doxycycline combination. | 2013 Jul |
1 |
| 32 |
23509364 | Epithelial-mesenchymal transition induces an antitumor immune response mediated by NKG2D receptor. | 2013 Apr 15 |
1 |
| 33 |
23645763 | A trial of autologous ex vivo-expanded NK cell-enriched lymphocytes with docetaxel in patients with advanced non-small cell lung cancer as second- or third-line treatment: phase IIa study. | 2013 May |
2 |
| 34 |
23679194 | Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications. | 2013 Aug |
1 |
| 35 |
23820258 | Downregulation of miR-302c and miR-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicity. | 2013 Aug 6 |
3 |
| 36 |
24370024 | [Effects of matrine on the expression of NKG2D ligands in leukemia cells]. | 2013 Dec |
1 |
| 37 |
22189020 | Identification and functional analysis of ligands for natural killer cell activating receptors in colon carcinoma. | 2012 Jan |
2 |
| 38 |
22242197 | Dynamic shift from CD85j/ILT-2 to NKG2D NK receptor expression pattern on human decidual NK during the first trimester of pregnancy. | 2012 |
1 |
| 39 |
22316211 | Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications. | 2012 Feb 8 |
1 |
| 40 |
23308050 | Valproic acid upregulates NKG2D ligand expression through an ERK-dependent mechanism and potentially enhances NK cell-mediated lysis of myeloma. | 2012 Dec |
1 |
| 41 |
23316196 | NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses. | 2012 |
1 |
| 42 |
21364924 | Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells. | 2011 Feb 25 |
1 |
| 43 |
21644031 | Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands. | 2011 Aug |
1 |
| 44 |
18791713 | Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis. | 2009 May |
1 |
| 45 |
17764010 | Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas. | 2008 Apr |
1 |
| 46 |
19000131 | Major histocompatibility complex class I chain-related gene A polymorphism and linkage disequilibrium with HLA-B alleles in Euro-Brazilians. | 2008 Dec |
3 |
| 47 |
17170457 | Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. | 2007 Jan |
1 |
| 48 |
17267578 | NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. | 2007 Jan 31 |
1 |
| 49 |
17332360 | Attenuation of the glucocorticoid response during Ad5IL-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors. | 2007 Mar 1 |
1 |
| 50 |
16621903 | Clinicopathological significance of major histocompatibility complex class I-related chain a and B expression in thyroid cancer. | 2006 Jul |
1 |